You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 608 Results of a phase 1 study investigating camidanlumab tesirine as monotherapy and in combination with pembrolizumab in patients with selected advanced solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
608 Results of a phase 1 study investigating camidanlumab tesirine as monotherapy and in combination with pembrolizumab in patients with selected advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023374018
Dec 202381015
Jan 2024120022
Feb 20249404
Mar 20248008
Apr 20248406
May 20249608
Jun 20247109
Jul 20244002
Aug 20246600
Sep 20245303
Oct 20247008
Nov 202496011
Dec 20243803
Jan 20254405
Feb 20251607
Mar 2025002
Apr 2025008
May 20250014
Jun 2025007
Total14230160